Advancements In Antibody Purification
Source: Cytiva
The demand for more efficient and agile downstream purification processes for diversified therapeutic antibody pipelines requires the development of new strategies and technologies.
Watch this webinar to learn from industry experts about:
- Emerging technologies and approaches for intensifying mAb purification
- Strategies for a diversified antibody pipeline including bispecific antibodies, fragments, and ADC
- How process development can improve process robustness, reduce risk, and speed time to market
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development
X
Subscribe to Biosimilar Development
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more